A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)

NCT03449134 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

732

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Cough

Interventions

DRUG: Placebo
DRUG: Gefapixant

Sponsor

Merck Sharp & Dohme LLC